These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37001883)

  • 21. Molecular basis and diagnostics of hereditary colorectal cancers.
    Abdel-Rahman WM; Peltomäki P
    Ann Med; 2004; 36(5):379-88. PubMed ID: 15478312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
    Thun MJ; Henley SJ; Patrono C
    J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
    Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E
    Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
    Chang K; Taggart MW; Reyes-Uribe L; Borras E; Riquelme E; Barnett RM; Leoni G; San Lucas FA; Catanese MT; Mori F; Diodoro MG; You YN; Hawk ET; Roszik J; Scheet P; Kopetz S; Nicosia A; Scarselli E; Lynch PM; McAllister F; Vilar E
    JAMA Oncol; 2018 Aug; 4(8):1085-1092. PubMed ID: 29710228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early detection of colorectal carcinoma. Pros and cons].
    von Betzler M
    MMW Fortschr Med; 2005 Apr; 147(14):26-8. PubMed ID: 15887679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory drugs and cancer prevention.
    Baron JA; Sandler RS
    Annu Rev Med; 2000; 51():511-23. PubMed ID: 10774479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
    Asano TK; McLeod RS
    Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology and genetics of hereditary colorectal cancer.
    Ma H; Brosens LAA; Offerhaus GJA; Giardiello FM; de Leng WWJ; Montgomery EA
    Pathology; 2018 Jan; 50(1):49-59. PubMed ID: 29169633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary intestinal polyposis syndromes.
    Dean PA
    Rev Gastroenterol Mex; 1996; 61(2):100-11. PubMed ID: 8927912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small bowel endoscopy in familial adenomatous polyposis and Lynch syndrome.
    Koornstra JJ
    Best Pract Res Clin Gastroenterol; 2012 Jun; 26(3):359-68. PubMed ID: 22704577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention with special reference to inherited colorectal cancer.
    Lynch PM
    Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive strategies in familial and hereditary colorectal cancer.
    Foda ZH; Dharwadkar P; Katona BW
    Best Pract Res Clin Gastroenterol; 2023 Oct; 66():101840. PubMed ID: 37852714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance recommendations for patients with Lynch syndrome and FAP : a monocentric study.
    Baert L; Claes K; De Man M; Tate DJ; Geboes K
    Acta Gastroenterol Belg; 2020; 83(3):399-405. PubMed ID: 33094586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary colorectal cancer: clinical consequences of predictive molecular testing.
    Hahn M; Saeger HD; Schackert HK
    Int J Colorectal Dis; 1999 Nov; 14(4-5):184-93. PubMed ID: 10647626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC.
    Lynch PM
    Digestion; 2007; 76(1):68-76. PubMed ID: 17947820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; Pérez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition and management of hereditary colorectal cancer syndromes.
    Herráiz M; Muñoz-Navas M
    Rev Esp Enferm Dig; 2009 Feb; 101(2):125-32. PubMed ID: 19335048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.